Literature DB >> 732246

Application of bradykinin radioimmunoassay for the measurement of urinary kallikrein activity rats.

M Stocker, J Hornung.   

Abstract

Bradykinin radioimmunoassay was applied for the measurement of urinary kallikrein activity in rats. Antisera against bradykinin were raised in rabbits by injecting synthetic bradykinin coupled to human serum albumin via a difluorodinitrobenzene reaction. For radioimmunoassay a high titre antibody was used at a final dilution of 1:65000 to bind approximately 8,000 cpm of [125I]-tyrosine8-bradykinin. Standard curves were plotted from synthetic bradykinin samples (1--1000 pg). Kinins were generated by incubating partially purified kininogen with rat urine in the presence of kininase inhibitors. Bradykinin antiserum showed crossreaction with kallidin, met-lys-bradykinin and dog-kininogen. To eliminate interference of the kininogen with kinin radioimmunoassay, alcohol precipitation of the substrate was performed after incubation. Concentration of urinary kallikrein in rats showed no significant difference between day and night 12-hours-colllecting period. Total kallikrein excretion at night, however, was about twofold higher, correlating to a twofold higher urine volume during the night.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 732246     DOI: 10.1007/bf01477463

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  4 in total

1.  Relationship between the renal kallikrein activity and the urinary excretion of kallikrein in rats.

Authors:  M Marin-Grez; G Schaechtelin; G Bönner
Journal:  Experientia       Date:  1982-08-15

2.  Increased kallikrein excretion in spontaneously hypertensive rats and its inhibition by 6-hydroxydopamine.

Authors:  W Rascher; G Bönner; M Stocker; F Gross
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

3.  The renal kallikrein-kinin system in spontaneously hypertensive rats.

Authors:  G Bönner; T Unger; W Rascher; G Speck; D Ganten; F Gross
Journal:  Agents Actions       Date:  1984-10

4.  Chronopharmacology of enalapril in hypertensive patients.

Authors:  K Sunaga; A Fujimura; T Shiga; A Ebihara
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.